Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of the American Chemical Society|May 2, 2002
Total synthesis of (-)-laulimalidePaul A Wender, Sayee G Hegde, Robert D Hubbard, et al.Drug Metabolism Letters|April 24, 2013
Application of 1D and 2D 1H-NMR in the structural elucidation of a N-glucuronidated metabolite and oxidized metabolites generated in microsomal incubationJulius L Apuy, April Bai, David Paisner, et al.Organic Letters|September 12, 2003
Synthesis and biological evaluation of (-)-laulimalide analoguesPaul A Wender, Sayee G Hegde, Robert D Hubbard, et al.Drug Metabolism Letters|May 12, 2016
Formation of A Novel Purine Metabolite through CYP3A4 Bioactivation and Glutathione ConjugationJulius L Apuy, Cathie Xiang, Sarah Franc, et al.Proceedings of the National Academy of Sciences of the United States of America|May 27, 2004
Microtubule-stabilizing agents based on designed laulimalide analoguesSusan L Mooberry, Deborah A Randall-Hlubek, Rachel M Leal, et al.Journal of Medicinal Chemistry|May 20, 2025
Discovery of an Orally Bioavailable and Brain Penetrant Selective Estrogen Receptor DegraderGuobao Zhang, Peter Q Huang, Kevin D Bunker, et al.Journal of Medicinal Chemistry|August 23, 2021
Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical Trials for the Treatment of CancerPeter Q Huang, Brant C Boren, Sayee G Hegde, et al.Journal of Medicinal Chemistry|July 14, 2025
Discovery of ZN-c5, an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) with Improved PharmacokineticsSayee G Hegde, Peter Q Huang, Kevin D Bunker, et al.Pageof 1